(R)-tert-Butyl (4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate

95%

Reagent Code: #230976
fingerprint
CAS Number 486460-23-5

science Other reagents with same CAS 486460-23-5

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 507.43 g/mol
Formula C₂₁H₂₃F₆N₅O₃
badge Registry Numbers
MDL Number MFCD29044848
thermostat Physical Properties
Melting Point 188-191 °C
inventory_2 Storage & Handling
Density 1.46±0.1 g/cm3(Predicted)
Storage 2-8°C, sealed, dry

description Product Description

Used as a key intermediate in the synthesis of antidiabetic drugs, particularly in the production of DPP-4 (dipeptidyl peptidase-4) inhibitors. Its structure enables selective binding and enhanced pharmacokinetic properties, making it valuable in developing oral medications for type 2 diabetes. The compound's fluorinated and heterocyclic components contribute to improved metabolic stability and bioavailability in final drug formulations.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 100mg
10-20 days ฿4,620.00
inventory 250mg
10-20 days ฿7,840.00
inventory 1g
10-20 days ฿21,160.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
Cart Checkout
(R)-tert-Butyl (4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate
No image available

Used as a key intermediate in the synthesis of antidiabetic drugs, particularly in the production of DPP-4 (dipeptidyl peptidase-4) inhibitors. Its structure enables selective binding and enhanced pharmacokinetic properties, making it valuable in developing oral medications for type 2 diabetes. The compound's fluorinated and heterocyclic components contribute to improved metabolic stability and bioavailability in final drug formulations.

Used as a key intermediate in the synthesis of antidiabetic drugs, particularly in the production of DPP-4 (dipeptidyl peptidase-4) inhibitors. Its structure enables selective binding and enhanced pharmacokinetic properties, making it valuable in developing oral medications for type 2 diabetes. The compound's fluorinated and heterocyclic components contribute to improved metabolic stability and bioavailability in final drug formulations.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Recommended Dosage -
Dosage (Per Day) -
Recommended Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...